Zinger Key Points
- Stephen L. Weiss says growth is still there in Meta Platforms.
- Kari Firestone says UnitedHealth Group is now starting to improve.
- China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the next trade alert free.
On CNBC's “Halftime Report Final Trades,” Stephen L. Weiss of Short Hills Capital Partners said Meta Platforms, Inc. META is selling at a discount to the market, which it should never do. So, the growth is still there, he added.
On Wednesday, Keybanc analyst Jason Celino maintained Meta with an Overweight rating and lowered the price target from $710 to $645, while B of A Securities analyst Justin Post maintained a Buy on the stock and cut the price target from $765 to $640.
Kari Firestone of Aureus Asset Management picked UnitedHealth Group Incorporated UNH, which has been in its own bear market. She noted that the stock is now starting to improve and is not affected by tariffs.
Supporting her view, Mizuho analyst Ann Hynes, on Wednesday, maintained UnitedHealth Group with an Outperform rating and raised the price target from $600 to $650.
Don't forget to check out our premarket coverage here
Bryn Talkington of Requisite Capital Management also picked Meta.
Joseph M. Terranova of Virtus Investment Partners suggested buying some calls in Invesco QQQ Trust QQQ in case they bounce.
Price Action:
- Meta shares gained 14.8% to close at $585.77 on Wednesday.
- UnitedHealth shares rose 4.6% to close at $578.50 during Wednesday's session.
- Invesco QQQ Trust jumped 12% during Wednesday's session.
Check This Out:
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.